In the News

Vaishali Mulchandani graduated from the Indian Institute of Science Education and Research, Kolkata (IISER-Kolkata) in 2023 with a PhD in Biological Sciences. Her PhD thesis was focused on understanding the importance of Connexin 43 (Cx43) trafficking and enhanced gap junctional intercellular communication formation in ovarian cancer development and metastasis.  She has recently joined the Gutmann […]

Angela C. Hirbe, the Director of the Adult NF Clinical Program, was recently promoted to the rank of Associate Professor with tenure in the Division of Medical Oncology. This is a major milestone in the career of a faculty member at Washington University, signifying excellence in research, recognition at a national level, and outstanding clinical […]

In this American Society of Clinical Oncology (ASCO) Daily News article, Dr. Angela Hirbe and her colleagues discuss the current data for using liquid biopsies (blood test) to attempt to diagnose cancer early.  Their team is working hard to make this a reality for NF1 patients! You can read the full article here.

Study lays groundwork for clinical trial aimed at preventing brain tumors in children with NF1. A drug used to treat children with epilepsy prevents brain tumor formation and growth in two mouse models of neurofibromatosis type 1 (NF1), according to a study by researchers at Washington University School of Medicine in St. Louis. NF1 is […]

Hannah Wang, an undergraduate student in Dr. David Gutmann’s laboratory, was recently awarded an Alex’s Lemonade Stand Foundation (ALSF) Pediatric Oncology Student Training (POST) summer research internship. The program was founded with the mission to change the lives of children with cancer through funding impactful research, raising awareness, supporting families, and empowering everyone to help […]